Stockreport

CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK [Yahoo! Finance]

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors
PDF the routine use of Respiratory Syncytial Virus (RSV) vaccines in all adults aged 75 and above The panel also recommended RSV immunization for adults aged 60-74 years w [Read more]